Author

Marina Grimaldi

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Patrick BalagueriD· 2 shared Abdelhay BoulahtoufiD· 1 shared Alexandre Evrard· 1 shared Alice MatheuxiD· 1 shared Amélie Gudin-de-ValleriniD· 1 shared Andrew C.B. CatoiD· 1 shared Barbara BellettiiD· 1 shared Céline GongoraiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Patrick BalaguerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The Pregnane X Receptor (PXR) contributes to phenotypic plasticity and modulates the sensitivity to targeted therapies in melanoma

Stefan D Nicolescu, Alice Matheux, Marina Grimaldi, Nadia Vie, Raphaël Romero, Mathilde Robin, Eric Fabbrizio, Abdelhay Boulahtouf, Julia Toucheboeuf, Amélie Gudin-de-Vallerin, Florence Boissière, Fanny Leenhardt, Litaty Mbatchi, Laura Tallevast, Patrick Balaguer, , Philippe Pourquier

This study shows that PXR expression in melanoma cells increases sensitivity to BRAFi/MEKi treatment and is linked to a melanocytic phenotype.

bioRxiv · Nov 4, 2026 · PreprintCancer Biology

Distinct 2-phenyl-imidazo pyridine derivatives drive ER degradation and selectively impair proliferation of ER+ breast cancer cells via the aryl hydrocarbon receptor

Katrin Koellisch, Christine Blattner, Stefano Motta, Janine Wesslowski, Melanie Rothley, Simone Büchel, Savannah Sirounian, Julia Müller, Marina Grimaldi, Jutta Stober, Zoe Wammetsberger, Mengwu Pan, René Houtman, Christoph W. Grathwol, Ilenia Segatto, , Andrew C.B. Cato

The paper identifies X15695 as an AHR ligand that promotes ER degradation and inhibits ER+ breast cancer cell proliferation more effectively than fulvestrant.

bioRxiv · Jul 28, 2025 · PreprintCancer Biology